EcoDrugPlus

Toll-Like Receptor 2

Ensembl ID : ENSHBUG00000019530
Gene Symbol: LOC102301752
3 Cross references
213 Possible Orthologues:

Toll-Like Receptor 8

Ensembl ID : ENSHBUG00000015304
Gene Symbol: LOC102294185
2 Cross references
178 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSHBUG00000001363
Gene Symbol: LOC102297452
3 Cross references
584 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSHBUG00000020022
Gene Symbol: TRPA1
3 Cross references
200 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSHBUG00000021751
Gene Symbol: LOC102314239
3 Cross references
176 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSHBUG00000010549
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tubulin Alpha 1c

Ensembl ID : ENSHBUG00000006666
Gene Symbol: TUBA1C
4 Cross references
189 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSHBUG00000002247
Gene Symbol: LOC102301689
3 Cross references
151 Possible Orthologues:

Tubulin Alpha-1c Chain-Like

Ensembl ID : ENSHBUG00000010533
Gene Symbol: LOC102310614
2 Cross references
170 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSHBUG00000009384
Gene Symbol: LOC102288730
2 Cross references
89 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSHBUG00000016882
Gene Symbol: TUBB
3 Cross references
183 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSHBUG00000000132
Gene Symbol: LOC102295499
3 Cross references
305 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).